Hip fractures

Summary

Pooled results from 13 randomized controlled trials showed a significant reduction in overall risk of DVT with use of heparin compared with no heparin in hip fracture patients. However, inadequate reporting of pulmonary embolism, death and other complications, along with inconsistent diagnostic methods across studies prevents meaningful conclusions from being drawn in regards to other outcomes. Better quality trials with consistent follow-up and event monitoring are needed in order to examine the effect heparin may have on clinically significant outcomes following hip fracture surgery.